Tag Archives: Roche Group


Ventana Receives Manufacturing Excellence Award

The Association for Manufacturing Excellence (AME) will bestow upon Ventana Medical Systems Inc. a 2014 Manufacturing Excellence Award. Vice President of the AME Manufacturing Excellence Awards Council Michael Bremer will visit Ventana on Oct. 29 to present the award. The company will officially be honored during the 2014 AME International Excellence Inside Conference, Nov. 10-14 in Jacksonville, Florida.

The AME Manufacturing Excellence Award is the premier award for excellence in manufacturing operations. The award recognizes leaders demonstrating best practices in continuous improvement methodology, creativity and innovation. The rigorous selection process begins when a company submits an extensive achievement report highlighting their efforts implementing continuous improvement practices across the entire value stream, covering manufacturing best practices, supply-chain flow, product development, safety initiatives and people powered excellence.

The AME assessment team then evaluates achievement reports against established criteria. Companies that receive the overall highest achievement scores are selected for an on-site visit by industry-expert auditors. Over the course of two days, auditors verify the information in the report, confirm that continuous improvement practices are embedded in the company culture and that senior management is engaged in the process. Award winners are selected based on the combined results of the achievement report and the on-site visit.

“Each year, a significant number of companies submit applications for these awards, with only a select few make it through to our final round of considerations,” said AME President Barbara Morrison. “AME Manufacturing Excellence Award recipients are a class above the rest—they represent the pinnacle of operational excellence in action.”

The AME assessment team praised Ventana for its dedication to accountability and for taking great care of employees, customers and the community. The assessors also praised the company, remarking “The commitment by Ventana to their cultural beliefs is definitely a best practice of people-centered leadership combined with enterprise excellence, which is a core tenant of AME.” They also lauded the progress and improvements the company has achieved in the last three years, stating, “We believe … [the] Ventana focus on excellence in every aspect of the company will provide a thriving future…”

“This was one of the best audits,” commented Himanshu Parikh, vice president of Manufacturing Operations at Ventana. “We were able to work with industry leaders during the audit process to get affirmation of our lean journey and embedded continuous improvement culture. The insight provided by the auditors will be valuable as we continue with our journey.”

Ventana Medical Systems Inc. is a member of the Roche Group. Founded in 1985, the company today employs 1,200 people and manufactures and distributes over 250 unique cancer diagnostic tests and related instruments worldwide. Ventana is committed to improving the lives of all patients afflicted with cancer.

TCP-Ventana, CBRE, WEB

Ventana leases 60KSf build-to-suit in Marana

An affiliate of Cottonwood Properties announced they will be constructing and leasing a 60,000 square foot distribution facility for Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group. The new facility is located in Tangerine Commerce Park located on Tangerine Farms Road just west of the Tangerine Road freeway interchange. This is the first development within the 100-acre business park that provides a range of retail and employment uses and will be a key location for future employment and retail growth in the Marana area. Financial terms of the transaction were not disclosed.

Bill Di Vito and Jesse Blum with CBRE’s Tucson office represented Cottonwood in the transaction. Ventana Medical Systems, Inc. was represented by Dev Gupta with DTZ.

“The Tangerine Corridor is an ideal location for this type of development,” said CBRE’s Di Vito. “Freeway access and the availability of larger commercial parcels will attract other logistics and employment users to the area, establishing it as the next major commercial hub in greater Tucson.”

The distribution facility is being designed by Gromatzky Dupree and Associates and construction with Barker Morrissey Contracting is scheduled to start in 4Q 2014 with completion projected for 4Q 2015.

Ventana Medical Systems, Inc., headquartered in Oro Valley, Ariz., is a member of the Roche Group and is a world leader and innovator of tissue-based cancer diagnostic solutions for patients worldwide. At its existing facility, located in the master-planned business community of Innovation Park, Ventana delivers medical diagnostic systems and biopsy-based cancer tests that are shaping the future of healthcare. This new facility will function as a multi-use distribution facility with some assembly to support its facility in Oro Valley.

Tangerine Commerce Park is located just off Interstate-10 on Tangerine Road and is the only mixed-use and industrial development along the quickly developing Tangerine Corridor with direct access to Oro Valley and the bio-tech industries. The park can accommodate uses from smaller 2- to 3-acre requirements up to 100-acre requirements.


TGen, Ventana announce research collaboration

The Translational Genomics Research Institute (TGen) and Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced a collaborative research agreement to discover and develop diagnostic markers for treating cancer.

The two Arizona-based institutions will leverage each other’s expertise in discovery and diagnostic product development, bringing innovative cancer diagnostic tests to patients.

The first project under the umbrella research agreement will focus on diagnostic, prognostic and drug biomarkers for pancreatic cancer, the fourth leading cause of death from cancer in the United States. This year, an estimated 45,000 people will be diagnosed and more than 38,000 patients will die from the disease. Worldwide, more than 213,000 are diagnosed with pancreatic cancer each year, and the numbers are growing. Fewer than 1 in 4 pancreatic cancer patients survive more than a year, and fewer than 6 percent survive more than five years – the worst survival rate of any cancer.

This dismal picture of pancreatic cancer is mainly due to the lack of tools for early detection and the ineffectiveness of current therapeutics. This is why new diagnostic markers and more efficacious therapies are desperately needed.

“TGen is on the cutting edge of translational research, where investigators discover the genetic components of disease,” says Jeffrey Trent, Ph.D., President and Research Director of TGen. “Our goal is to rapidly translate basic research findings into actionable targets. Partnering with Ventana we hope will accelerate our goal to deliver meaningful discoveries to cancer patients today.”

“When a patient is faced with cancer, getting an accurate diagnosis quickly is the most important part of their treatment,” says Ventana President and CEO Mara G. Aspinall. “As the global leader in tissue-based cancer diagnostics, our strength is moving research into the clinic in order to improve the lives of all patients afflicted with cancer. We are thrilled to be able to pursue this with a partner right in our Arizona backyard.”